rs77358650

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBA1

The NM_001130438.3(SPTAN1):​c.1330G>A​(p.Val444Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00312 in 1,612,962 control chromosomes in the GnomAD database, including 142 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0028 ( 10 hom., cov: 31)
Exomes 𝑓: 0.0032 ( 132 hom. )

Consequence

SPTAN1
NM_001130438.3 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts P:1U:1B:8

Conservation

PhyloP100: -0.0890
Variant links:
Genes affected
SPTAN1 (HGNC:11273): (spectrin alpha, non-erythrocytic 1) Spectrins are a family of filamentous cytoskeletal proteins that function as essential scaffold proteins that stabilize the plasma membrane and organize intracellular organelles. Spectrins are composed of alpha and beta dimers that associate to form tetramers linked in a head-to-head arrangement. This gene encodes an alpha spectrin that is specifically expressed in nonerythrocytic cells. The encoded protein has been implicated in other cellular functions including DNA repair and cell cycle regulation. Mutations in this gene are the cause of early infantile epileptic encephalopathy-5. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Sep 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), SPTAN1. . Gene score misZ 5.523 (greater than the threshold 3.09). Trascript score misZ 7.9287 (greater than threshold 3.09). GenCC has associacion of gene with developmental and epileptic encephalopathy, 5, developmental and epileptic encephalopathy, West syndrome.
BP4
Computational evidence support a benign effect (MetaRNN=0.004676819).
BP6
Variant 9-128580928-G-A is Benign according to our data. Variant chr9-128580928-G-A is described in ClinVar as [Benign]. Clinvar id is 139269.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-128580928-G-A is described in Lovd as [Pathogenic]. Variant chr9-128580928-G-A is described in Lovd as [Benign]. Variant chr9-128580928-G-A is described in Lovd as [Likely_benign].
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0516 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTAN1NM_001130438.3 linkuse as main transcriptc.1330G>A p.Val444Ile missense_variant 11/57 ENST00000372739.7 NP_001123910.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTAN1ENST00000372739.7 linkuse as main transcriptc.1330G>A p.Val444Ile missense_variant 11/571 NM_001130438.3 ENSP00000361824 P3Q13813-2

Frequencies

GnomAD3 genomes
AF:
0.00281
AC:
428
AN:
152194
Hom.:
9
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000772
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00519
Gnomad EAS
AF:
0.0407
Gnomad SAS
AF:
0.0275
Gnomad FIN
AF:
0.000753
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00336
GnomAD3 exomes
AF:
0.00522
AC:
1311
AN:
251106
Hom.:
22
AF XY:
0.00581
AC XY:
788
AN XY:
135710
show subpopulations
Gnomad AFR exome
AF:
0.000800
Gnomad AMR exome
AF:
0.000405
Gnomad ASJ exome
AF:
0.00536
Gnomad EAS exome
AF:
0.0290
Gnomad SAS exome
AF:
0.0206
Gnomad FIN exome
AF:
0.000187
Gnomad NFE exome
AF:
0.000255
Gnomad OTH exome
AF:
0.00554
GnomAD4 exome
AF:
0.00315
AC:
4604
AN:
1460650
Hom.:
132
Cov.:
31
AF XY:
0.00363
AC XY:
2635
AN XY:
726642
show subpopulations
Gnomad4 AFR exome
AF:
0.000628
Gnomad4 AMR exome
AF:
0.000313
Gnomad4 ASJ exome
AF:
0.00513
Gnomad4 EAS exome
AF:
0.0535
Gnomad4 SAS exome
AF:
0.0208
Gnomad4 FIN exome
AF:
0.000150
Gnomad4 NFE exome
AF:
0.000185
Gnomad4 OTH exome
AF:
0.00494
GnomAD4 genome
AF:
0.00282
AC:
430
AN:
152312
Hom.:
10
Cov.:
31
AF XY:
0.00332
AC XY:
247
AN XY:
74464
show subpopulations
Gnomad4 AFR
AF:
0.000770
Gnomad4 AMR
AF:
0.000457
Gnomad4 ASJ
AF:
0.00519
Gnomad4 EAS
AF:
0.0404
Gnomad4 SAS
AF:
0.0282
Gnomad4 FIN
AF:
0.000753
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00380
Alfa
AF:
0.00154
Hom.:
8
Bravo
AF:
0.00165
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000908
AC:
4
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.00566
AC:
687
Asia WGS
AF:
0.0520
AC:
181
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000119

ClinVar

Significance: Benign
Submissions summary: Pathogenic:1Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJun 01, 2024SPTAN1: BP4, BS1, BS2 -
Benign, criteria provided, single submitterclinical testingGeneDxNov 16, 2018This variant is associated with the following publications: (PMID: 26539891, 31180159) -
Uncertain significance, no assertion criteria providedclinical testingDepartment of Pathology and Laboratory Medicine, Sinai Health System-- -
not specified Benign:2
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoFeb 08, 2016- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 19, 2015- -
Developmental and epileptic encephalopathy, 5 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Abnormal brain morphology Pathogenic:1
Likely pathogenic, flagged submissionresearchLupski Lab, Baylor-Hopkins CMG, Baylor College of Medicine-- -
Inborn genetic diseases Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsFeb 10, 2017This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Early infantile epileptic encephalopathy with suppression bursts Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.055
BayesDel_addAF
Benign
-0.71
T
BayesDel_noAF
Benign
-0.73
CADD
Benign
0.013
DANN
Benign
0.83
DEOGEN2
Benign
0.096
T;.;.;.;.
Eigen
Benign
-1.8
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.030
N
LIST_S2
Benign
0.59
T;T;T;T;T
MetaRNN
Benign
0.0047
T;T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
-0.90
N;.;N;N;.
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.26
T
PROVEAN
Benign
-0.23
N;.;N;N;.
REVEL
Benign
0.038
Sift
Benign
0.66
T;.;T;T;.
Sift4G
Benign
0.35
T;T;T;T;T
Polyphen
0.0010
B;.;B;B;.
Vest4
0.52
MVP
0.17
MPC
0.63
ClinPred
0.0034
T
GERP RS
-11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.015
gMVP
0.017

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs77358650; hg19: chr9-131343207; COSMIC: COSV63987177; COSMIC: COSV63987177; API